Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityJohn W. Shiver, Rima Youil, Virginia Harris et al.|Nature|2002Cited by 1.2k
Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA VaccinationDan H. Barouch, Norman L. Letvin, Sampa Santra et al.|Science|2000Cited by 885
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisM. Juliana McElrath, Danilo R. Casimiro, Stephen C. De Rosa et al.|The Lancet|2008Cited by 699
Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 <i>gag</i> GeneDanilo R. Casimiro, John W. Shiver, Ling Chen et al.|Journal of Virology|2003Cited by 398
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy AdultsFrances Priddy, Deborah D. Brown, James G. Kublin et al.|Clinical Infectious Diseases|2008Cited by 246